99 related articles for article (PubMed ID: 28620803)
1. Impact of Pharmacy Proximity and Delivery Services on HIV Viral Suppression Among Low Income Urban Patients.
Pham N; Lewis S; Avery A
AIDS Behav; 2018 Mar; 22(3):1025-1029. PubMed ID: 28620803
[TBL] [Abstract][Full Text] [Related]
2. Outpatient pharmacy care and HIV viral load response among patients on HAART.
Castillo E; Palepu A; Beardsell A; Akagi L; Yip B; Montaner JS; Hogg RS
AIDS Care; 2004 May; 16(4):446-57. PubMed ID: 15203413
[TBL] [Abstract][Full Text] [Related]
3. The Effect of an Integrated Health System Specialty Pharmacy on HIV Antiretroviral Therapy Adherence, Viral Suppression, and CD4 Count in an Outpatient Infectious Disease Clinic.
Barnes E; Zhao J; Giumenta A; Johnson M
J Manag Care Spec Pharm; 2020 Feb; 26(2):95-102. PubMed ID: 32011966
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.
Hayashi K; Wood E; Kerr T; Dong H; Nguyen P; Puskas CM; Guillemi S; Montaner JS; Milloy MJ
BMC Infect Dis; 2016 Aug; 16(1):455. PubMed ID: 27568002
[TBL] [Abstract][Full Text] [Related]
5. Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?
Mekuria LA; Prins JM; Yalew AW; Sprangers MA; Nieuwkerk PT
Trop Med Int Health; 2016 Jul; 21(7):856-69. PubMed ID: 27118068
[TBL] [Abstract][Full Text] [Related]
6. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral adherence and virological outcomes in HIV-positive patients in Ugu district, KwaZulu-Natal province.
Kapiamba G; Masango T; Mphuthi D
Afr J AIDS Res; 2016 Sep; 15(3):195-201. PubMed ID: 27681144
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
Silveira MP; Maurer P; Guttier MC; Moreira LB
J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
[TBL] [Abstract][Full Text] [Related]
9. Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda.
Musinguzi N; Mocello RA; Boum Y; Hunt PW; Martin JN; Haberer JE; Bangsberg DR; Siedner MJ
AIDS Behav; 2017 Jun; 21(6):1735-1740. PubMed ID: 27256394
[TBL] [Abstract][Full Text] [Related]
10. Correlation between medication adherence using proportion of days covered and achieving viral suppression in patients living with HIV.
Komandt M; Canfield S; Lengel M; Gilmore V; Kilcrease C
J Manag Care Spec Pharm; 2023 Oct; 29(10):1129-1137. PubMed ID: 37776120
[No Abstract] [Full Text] [Related]
11. Evaluating adherence to medication in children and adolescents with HIV.
Khan M; Song X; Williams K; Bright K; Sill A; Rakhmanina N
Arch Dis Child; 2009 Dec; 94(12):970-3. PubMed ID: 19723637
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with 10 years of continuous viral load suppression on HAART.
Bello KJ; Mesner O; O'Bryan TA; Won SH; Lalani T; Ganesan A; Agan BK; Okulicz JF
BMC Infect Dis; 2016 Jul; 16():351. PubMed ID: 27449671
[TBL] [Abstract][Full Text] [Related]
13. Self-reported adherence and pharmacy refill adherence are both predictive for an undetectable viral load among HIV-infected migrants receiving cART.
Been SK; Yildiz E; Nieuwkerk PT; Pogány K; van de Vijver DAMC; Verbon A
PLoS One; 2017; 12(11):e0186912. PubMed ID: 29121665
[TBL] [Abstract][Full Text] [Related]
14. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
15. Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda.
Bagenda A; Barlow-Mosha L; Bagenda D; Sakwa R; Fowler MG; Musoke PM
Ann Trop Paediatr; 2011; 31(3):235-45. PubMed ID: 21781419
[TBL] [Abstract][Full Text] [Related]
16. Impact of mail order pharmacy use and travel time to pharmacy on viral suppression among people living with HIV.
Ridgway JP; Friedman EE; Choe J; Nguyen CT; Schuble T; Pettit NN
AIDS Care; 2020 Nov; 32(11):1372-1378. PubMed ID: 32362129
[TBL] [Abstract][Full Text] [Related]
17. Association of Depressive Symptoms with Lapses in Antiretroviral Medication Adherence Among People Living with HIV: A Test of an Indirect Pathway.
Babowitch JD; Sheinfil AZ; Woolf-King SE; Vanable PA; Sweeney SM
AIDS Behav; 2018 Oct; 22(10):3166-3174. PubMed ID: 29572762
[TBL] [Abstract][Full Text] [Related]
18. The Role of Pharmacy Refill Measures in Assessing Adherence and Predicting HIV Disease Markers in Youth with Perinatally-Acquired HIV (PHIV).
Yildirim C; Garvie PA; Chernoff M; Wilkins ML; Patton ED; Williams PL; Nichols SL;
AIDS Behav; 2019 Aug; 23(8):2109-2120. PubMed ID: 30929147
[TBL] [Abstract][Full Text] [Related]
19. Adherence to antiretroviral therapy in pediatric patients with human immunodeficiency virus (HIV-1).
Burack G; Gaur S; Marone R; Petrova A
J Pediatr Nurs; 2010 Dec; 25(6):500-4. PubMed ID: 21035017
[TBL] [Abstract][Full Text] [Related]
20. Determination of the influence of home delivery of HIV therapy on virological outcomes and adherence.
Castelino S; Miah H; Auyeung V; Vogt F
Int J STD AIDS; 2015 Feb; 26(2):93-7. PubMed ID: 24733153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
